Richard V. Goering, PhD
Richard V. Goering, PhD

Richard V. Goering, PhD

Professor
School of Medicine

Academic Appointments

Department

  • Med. Microbiology & Immunology

Position

  • Professor

Biography

Examples of the most recent publications can be obtained from this PubMed link.

Education

  • Wichita State University,A.B.,to 1966
  • Wichita State University,M.S.,to 1968
  • Iowa State University,Ph.D.,to 1968

Publications and Presentations

Books

  • 1. Chung, M, H. De Lencastre, P. Matthews, A. Tomaz, I. Adamsson, M. A. De Sousa, T. Camou, C. Cocuzza, A. Corso, I. Couto, A. Dominguez, M. Gniadkowski, R. Goering, A. Gomes, K. Kikuchi, A. Marchese, R. Mato, O. Melter, D. Oliveira, R. Palacio, R. Sa-Leao, I. Santos Sanches, J-H. Song, P. T. Tassios, and P. Villari. 2000. Molecular Typing of Methicillin-Resistant Staphylococcus aureus by Pulsed-Field Gel Electrophoresis: Comparison of Results Obtained in a Multilaboratory Effort Using Identical Protocols and MRSA Strains. Microb. Drug Resist. 6:189-198., Microbial Drug Resistance, 189-198, 2000
  • 2. Goering, R.V., C-E Nord, R. Hare, F. Sabatelli, and the Ziracin Susceptibility Testing Group. 2000. In vitro activity of evernimicin and selected antibiotics against methicillin-resistant staphylococci: a 24-country study. Clin. Microbiol. Infect. 6:549-556, Clinical Microbiology Infectious Disease, 549-556, 2000
  • 3. Goering, R.V. 2000. The molecular epidemiology of nosocomial infection: past, present, and future. Rev. Med. Microbiol. 11:1-8., Rev. Med. Microbiol., 1-8, 2000
  • 4. Goering, R.V. 2000. Rapid test methods. In APIC text of infection control and epidemiology. Association for Professionals in Infection and Control and Epidemiology, Inc., Washington, DC. Chapter 70, pp. 1-10., Academic Medicine, 1-10, 2000
  • 5. Goering, R.V. 2000. How to select and interpret molecular methods for epidemiological study of bacterial infections. Microbiol. Med. 15:92, Microbiol. Med., 92, 2000

Articles

  • Nimmo, G.R., J.A. Steen, S. Monecke, R. Ehricht, P. Slickers, J.C. Thomas, S. Appleton, R.V. Goering, D.A. Robinson, and G.W. Coombs. ST2249-MRSA-III: a second major recombinant methicillin-resistant Staphylococcus aureus clone causing healthcare infection in the 1970s., Clinical Microbiology Infectious Disease, 21, 444-450, 2015
  • Spinali S, A. van Belkum, R.V. Goering, V. Girard, M. Welker, M. Van Nuenen, D.H. Pincus, M. Arsac, and G. Durand. Microbial typing by MALDI-TOF MS: do we need guidance for data interpretation?, J Clinical Microbiology, 53, 760-765, 2015
  • Lopez-Valladares, G., M. L. Danielsson-Tham, R. V. Goering, and W. Tham. 2015. Division of Human Listeria monocytogenes Pulsed-Field Gel Electrophoresis (PFGE) Types Belonging to Lineage I (Serovar 4b, 1/2b, and 3b) into PFGE Groups, Foodborne Pathogens and Disease, 12, 447-453, 2015
  • Leopold, S. R., R. V. Goering, A. Witten, D. Harmsen, and A. Mellmann. Bacterial whole genome sequencing revisited: portable, scalable and standardized analysis for typing and detection of virulence and antibiotic resistance genes, Journal of Clinical Microbiology, 52, 2365-2370, 2014
  • Tickler, I. A., R. V. Goering, J. D. Whitmore, A. N. Lynn, D. H. Persing, and F. C. Tenover. Strain Types and Antimicrobial Resistance Patterns of Clostridium difficile Isolates from the United States: 2011-2013, Antimicrob Agents Chemother, 58, 4214-4218, 2014
  • Locke, J. B., D. E. Zuill, C. R. Scharn, J. Deane, D. F. Sahm, G. A. Denys, R. V. Goering, and K. J. Shaw. Linezolid-resistant Staphylococcus aureus strain 1128105, the first known clinical isolate possessing the cfr multidrug resistance gene, Antimicrob Agents Chemother, 58, 6592-6598, 2014
  • Locke, J. B., D. E. Zuill, C. R. Scharn, J. Deane, D. F. Sahm, R. V. Goering, S. G. Jenkins, and K. J. Shaw. Identification and characterization of linezolid-resistant cfr-positive Staphylococcus aureus USA300 isolates from a New York City medical center, Antimicrob Agents Chemother, 58, 6949-6952, 2014
  • Goering, R.V. and P.D. Fey. 2014. Pulsed field gel electrophoresis of Staphylococcus epidermidis, Methods in Molecular Biology, 1106, 55-60, 2014
  • R. V. Goering, K.L.F. Cooper, K.L. Rogers, P. M. Schlievert, J. Parsonnet, C. Davis, M. Hansmann, and P. D. Fey. 2006. Genomic Interrelationship Between mecA-positive and mecA-negative Toxic Shock Syndrome Toxin-1 Producing Staphylococcus aureus Isolates in the United States., Antimicrob Agents Chemother, 2006
  • Kristin K. Bonnstetter, Daniel J. Wolter, Fred C. Tenover, Linda K. McDougal, and Richard V. Goering. 2006. Rapid Multiplex PCR Assay for Identification of USA300 Community-Associated Methicillin-Resistant Staphylococcus aureus Isolates., J Clinical Microbiology, 2006
  • Tenover, F. C., L. K. McDougal, R. V. Goering, G. Killgore, S. J. Projan, J. B. Patel, and P. M. Dunman. 2006. Characterization of a Widely Disseminated Strain of Community-Associated Methicillin-Resistant Staphylococcus aureus from the United States., J Clinical Microbiology, 5:28-33, 108-118, 2006
  • • Hossain, A., M. J. Ferraro, R. M. Pino, R. B. Dew, III, E. S. Moland, T. J. Lockhart, K. S. Thomson, R. V. Goering, and N. D. Hanson. 2004. Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp. Antimicrob.Agents Chemother., Antimicrob Agents Chemother, 48, 4438-4440, 2004
  • • Wolter, D.J., E.S.Moland, R.V. Goering, N.D. Hanson, and P.D. Lister. 2004. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital. Diag. Microbiol. Infect. Dis. 50:43-50., Diagnosis Microbiol Infectious Diseases, 50, 43-50, 2004
  • Questions study on Escherichia coli susceptibility, J Am. Vet. Med., 220, 1139-1141, 2003
  • Cooper, K.F.C. and R. V. Goering. 2003. Development of a universal probe for electronic microarray and its application in characterization of the Staphylococcus aureus polC gene., J Molec Diag, 5, 28-33, 2003
  • In D.H. Persing, , F.C. Tenover, J. Versalovic, Y. Tank, B. Unger, D. Relman and T.J. White (eds.), Molecular Microbiology: Diagnostic Principles and Practice. ASM Press, Washington, D.C., Not Applicable, Chapter 15, pp. 185-196, 2003
  • The influence of genomics on the molecular epidemiology of nosocomial pathogens., Not Applicable, In K J. Shaw (ed.), Pathogen Genomics. Humana Press, Inc., Totowa, N.J, Chapter 9, pp. 113-131, 2003
  • Goering, R.V.*, J. Parsonnet, C. Davis, and J. Seymour. 2002. Frequency of Methicillin Resistance in Toxic Shock Syndrome Toxin -1 (TSST-1) Positive Staphylococcus aureus Isolates of Diverse Geographic Origin., Not Applicable, C2-1120, 2003
  • Moland, E.S., N. Hanson, V. Herrera, J. Black, T. Lockhart, A. Hossain, J. Johnson, R.V. Goering, and K.S. Thomson. Plasmid-Mediated Carbapenem-Hydrolyzing ß-lactamase, KPC-2, in Klebsiella pneumoniae Isolates., Journal of Antimicrobial Chemotherapy, 51:, 711-714., 2003
  • 6. Goering, R.V. 2000. Molecular strain typing for the clinical laboratory: current application and future direction. Clin. Microbiol. News. 22:169-173, Clin. Microbiol. News., 169-173, 2000
  • Wiener, J., J.P. Quinn, P.A. Bradford, R.V. Goering, C. Nathan, K. Bush, and R.A. Weinstein. 1999. Nursing homes as reservoirs of multiple-antibiotic resistant Klebsiella and Escherichia coli. J. Amer. Med. Assoc. 281:517-523;, Not Applicable, 1999
  • Walker, J., R. Borrow, R.V. Goering, S. Egerton, A.J. Fox, and B.A. Oppenheim. 1999. Subtyping of methicillin-resistant Staphylococcus aureus isolates from the north west of England: a comparison of standardized pulsed field gel electrophoresis with bacteriophage typing including an inter-laboratory reproducibility study. J. Med. Microbiol. 48:297-301, Not Applicable, 1999
  • Davies, T., R.V. Goering, M. Lovgren, J.A. Talbot, M.R. Jacobs, and P.C. Appelbaum. 1999. Molecular epidemiology survey of penicillin-resistant Streptococcus pneumoniae from Asia, Europe, and North America. Diag. Microbiol. Infect. Dis. 34:7-12, Not Applicable, 1999

Publications

  • L. K. McDougal*, G. E. Fosheim, K. K. Bonnstetter, F. C. Tenover, D. J. Wolter, and R. V. Goering. 2006. Not all USA300 MRSA Isolates Contain the Arginine Catabolic Mobile Element (ACME), Antimicrob Agents Chemother, Abstr. 46th Intersci. Conf. , 2006
  • K.K. Bonnstetter*, D.J. Wolter, F.C. Tenover, L.K. McDougal, and R.V. Goering. 2006. Rapid Multiplex PCR Assay for Identification of USA300 Community-Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Isolates., American Society for Microbiology, Abstr.Annu.Meeting., C225, 2006
  • R.V. Goering*, A.R. Larsen, R. Skov, F.C. Tenover, K. Anderson, and P.M. Dunman. 2006. Comparative Genomic Analysis of Community-Acquired ST80-SCCmec IV Staphylococcus aureus Isolates by High-Density Microarray., 16th Eur.Congr.Clin.Microbiol.Infect.Dis., 0115, 2006
  • R.V. Goering*, C. Davis, M. Hansmann , J. Parsonnet , K.L. Rogers, and P.D. Fey. 2006. Genomic Interrelationship Between Toxic Shock Syndrome Toxin 1 Producing Staphylococcus aureus Isolates from North America and USA 200 – Epidemic MRSA., Abstr.Internat.Conf.Emerg.Infect.Dis., 440, 2006
  • A.R. Larsen*, R.V. Goering, L.V. Pallesen, R. Skov*. 2005. Community-Acquired Methicillin-Resistant Staphylococcus aureus ST80-IV clone in Denmark., 22nd Annu. Meeting Scand. Soc.Antimicrob.Chemother., P31, 2005
  • A. Chatterjee*, T. Bardon, N. Cornish, S. Plummer, B. Heybrock, K. Eischen, R.V. Goering, S. Lazoritz. 2005. Identification and Control of a Clonal Outbreak of Methicillin-Resistant Staphylococcus aureus Infections at a Level 3 Neonatal Intensive Care Unit., 15th Annual Meeting Society Healthcare Epidemiology.America, Amer., 125, 2005
  • A.R. Larsen*, R.V. Goering, L.V. Pallesen, R. Skov. 2005. Ten-year of Community-Acquired Methicillin-Resistant Staphylococcus aureus ST80-IV clone in Denmark., 15th Eur.Congr.Clin.Microbiol.Infect. Dis., P1177, 2005
  • Wolter, D.J.*, J. Black, D. Acquazzino, R. V. Goering, P. Sammut, and N. D. Hanson. 2003. Emergence of Fluoroquinolone (FQ) Resistant Pseudomonas aeruginosa in a Cystic Fibrosis (CF) Patient: Discordance Between MexEF-OprN and Carbapenem Susceptibility, Antimicrob Agents Chemother, C1-2063, 2003
  • Cooper, K.L.F.* and R.V. Goering. 2003. Epidemiological Analysis of Methicillin-Resistant Staphylococcus aureus (MRSA) by Multi-Locus Sequence Typing (MLST) vs. Electronic Microarray Analysis Using a Rapid Heteroduplex Approach. Sixth Internat. Meeting Bact. Epidemiol. Markers, Bact. Epidemiol., 2003
  • Goering, R.V.*, D. Morrison, K.F.C. Cooper, Z. Al-Doori, G.F.S. Edwards, and C.G. Gemmell. 2003. Improved Tracking of Epidemic Methicillin-Resistant Staphylococcus aureus in Scotland Using a Combination of Pulsed Field Gel Electrophoresis and mec-Associated dru Sequences., 13th Eur Congr. Clin. Microbiol. Infect. Dis., P1581, 2003
  • Cooper, K.L.F.* and R. V. Goering. 2003. Sequence-Based Epidemiological Analysis of Methicillin-Resistant Staphylococcus aureus (MRSA): Multi-Locus Sequence Typing (MLST) vs. Electronic Microarray Analysis Using polC and gyrA., American Society for Microbiology, C425, 2003
  • Goering, R.V.*, C. Davis, J. Seymour, and J. Parsonnet. 2003. Analysis of Genetic Background in Staphylococcus aureus Isolates from North America Producing Toxic Shock Syndrome Toxin 1., 13th Eur Congr. Clin. Microbiol. Infect. Dis., P1276, 2003
  • Goering, R.V.* and K.L.F. Cooper. 2003. A Universal Reporting Approach to the Detection of Single Nucleotide Polymorphisms in the Chromosome of Staphylococcus aureus Utilizing Electronic Microarrays., Soc. Appl. Microbiol., OP2, 2003
  • Cooper, K.* and R.V. Goering. 2002. Development of a Universal Reporting System for Microelectronic Array Analysis and its Application in Genetic Analysis of the GyrA Subunit of the DNA Gyrase Gene in Staphylococcus aureus., 42nd Intersci. Conf. Antimicrob. AGents Chemother., D-1441, 2003
  • Cooper, K.* and R.V. Goering. 2002. Development of a Universal Reporting System for Detecting Single Nucleotide Polymorphisms in the Chromosome of Staphylococcus aureus Utilizing an Electronic Microelectronic Array Format., Amer. Assoc. Clin. Chem. 17th San Diego Conf, 61800190, 2003
  • Instrument Based Approaches to the Management of Nocosomial Infections., Open Journal Modern Neurosurgery, ISW-16-1, 2003
  • Jabes, D.*, A. Bulgheroni, and R.V. Goering. 2002. Ramoplanin is active against E. gallinarum isolates from neutropenic patients expressing vanA, vanB and vanC resistance to vancomycin., 12th Eur. Congr. Clin. Microbiol. Infect. Dis., P132, 2003
  • Parsonnet, J., P. Modern, M. Tong, Y. Bi, J. Gajaraj, R. Goering, A. Weissfeld, M. Hansmann, C. Davis*, and J. Seymour. 2002. Carriage of Toxic Shock Syndrome-1 Positive Staphylococcus aureus and Prevalence of Antibody in Asian and North American Women., 10th Internat. Symb. Staph. and Staph Infect. 233-01, 233-01, 2003
  • Goering, R.V.*, K.L.F. Cooper, T.L. Bittner, and M. Healy. 2002. Usefulness of a Standardized rep-PCR Approach in the Epidemiological Analysis of Methicillin-Resistant Staphylococcus aureus (MRSA)., 10th Internat. Symb. Staph. and Staph Infect. 233-01, 260-01, 2003
  • 65. Shawar, R.*, R.V. Goering, D. Macleod, R. Garber, and K. Tanaka 1999. Comparison of Pulsed Field Gel Electrophoresis to PCR-based Molecular Typing of Pseudomonas aeruginosa From Patients With Cystic Fibrosis. Abstr. Annu. Meeting Amer. Soc. Microbiol. C402, Not Applicable, 1999

Presentations

  • 144. Goering, R.V., M. Bensaci, H. Patel*, and G. Thorne. Epidemiological Analysis of Methicillin-Resistant Staphylococcus aureus Isolates from Tedizolid Clinical Studies. Abstr. 25th Eur. Congr. Clin. Microbiol. Infect. Dis. EP086, 2015
  • • A.R. Larsen*, R.V. Goering, L.V. Pallesen, R. Skov. 2005. Ten-year of Community-Acquired Methicillin-Resistant Staphylococcus aureus ST80-IV clone in Denmark. 15th Eur. Congr. Clin. Microbiol. Infect. Dis. P1177, 2005
  • Chatterjee*, S.D. Plummer, B. Heybrock, K. Eischen, and R. V. Goering. 2004. Infection Control Goes Molecular: The Role of Pulsed Field Gel Electrophoresis in the Practice of Hospital Epidemiology at a Children’s Hospital. 14th Annu. Meeting Soc. Healthcare Epidemiol. Amer. 267, 2004
  • • Chatterjee*, T. Bardon, N. Cornish, S. Plummer, B. Heybrock, K. Eischen, R.V. Goering, S. Lazoritz. 2005. Identification and Control of a Clonal Outbreak of Methicillin-Resistant Staphylococcus aureus Infections at a Level 3 Neonatal Intensive Care Unit. 15th Annu. Meeting Soc. Healthcare Epidemiol. Amer. 125, 2004
  • 1. Goering, R.V.* and K.L.F. Cooper. 2000. Improved Epidemiological Analysis of Methicillin Resistant Staphylococcus aureus by RAPD Using a Thermostable Polymerase with 3’ to 5’ Proofreading Activity. Fifth Internat. Meeting Bact. Epidemiol. Markers (Noordwijkerhout, The Netherlands). S7-02, 2000
  • 2. Goering, R.V.*, M. Fincham, F. Vandenesch, and J. Etienne. 2000. A Genotypic Comparison of Staphylococcus lugdunensis Clinical Isolates of Diverse Geographic Origin. 10th Eur. Congr. Clin. Microbiol. Infect. Dis. MoP338., 2000
  • 3. Goering, R.V.* 2000. Genomic Organization of Ribosomal RNA Genes in Staphylococci. 9th Internat. Symp. Staph. and Staph. Infect. #93/HP13., 2000
  • 4. Goering, R.V.* 2000. An Integrated Approach to the Epidemiological Analysis of Nosocomial Pathogens Using a Combination of Pulsed Field Gel Electrophoresis and PCR. Fifth Internat. Meeting Bact. Epidemiol. Markers (Noordwijkerhout, The Netherlands). P040, 2000
  • Presentations at four other Japanese hospitals 10/20/99-10/23/99, 1999
  • Japan Antibiotics Symposium, 10/19/99;, 1999
  • University of Tokyo, 10/19/99, 1999
  • Molecular epidemiology of infectious disease, Copenhagen, Denmark, 10/14/99, 1999
  • APIC Minnesota, 10/9/99, 1999
  • ICAAC 9/24/99, 1999
  • APIC Florida, 9/17/99, 1999
  • IMSS Mexico City Nosocomial Infection Workshop, 8/24/99-8/29/99, 1999
  • WIP, 5/5/99, 1999
  • Mt. Siani Hospital, NY, 4/26/99, 1999
  • SHEA epiedmiology workshop, 4/17/99, 1999
  • NYAS, 3/17/99, 1999
  • NYAS 3/17/99, 1999
  • ASM, 3/2/99, 1999
  • Dept. Pathology, CUSOM, 2/18/99, 1999

Research and Scholarship

Research and Scholarship Interests

  • My laboratory is actively involved in the application of molecular techniques to the diagnosis, study of antibiotic resistance, and the epidemiological analysis (i.e., molecular epidemiology) of infectious diseases with a special emphasis on Clostridium difficile, staphylococci, and staphylococcal diseases. We are especially interested in the impact whole genome sequencing (WGS) is having on these areas of investigation.  Especially with regard to epidemiological analysis, the use of WGS remains in need of clarified sequencing protocols and guidelines for bioinformatic data analysis and interpretation - areas we are actively pursuing with a variety of collaborators both corporate and academic.

Current Research Projects

Awards and Honors

  • PCT-IDENTIFICATION OF USA300 COMMUNITY-ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (Patent No: PCT/US2006/043780), 2006
  • PROVISIONAL - IDENTIFICATION OF USA300 COMMUNITY-ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS ISOLATES (Patent No: 60/816,803), 2006
  • Provisional - IDENTIFICATION OF USA300 COMMUNITY-ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS ISOLATES (Patent No: 60/736,147), 2005
  • “Highly Commended” recognition by The Society of Authors and the Royal Society of Medicine in London, 2004